A detailed history of Privium Fund Management B.V. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 27,709 shares of NTLA stock, worth $262,127. This represents 0.07% of its overall portfolio holdings.

Number of Shares
27,709
Previous 12,300 125.28%
Holding current value
$262,127
Previous $252,000 28.17%
% of portfolio
0.07%
Previous 0.06%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$11.41 - $21.09 $175,816 - $324,975
15,409 Added 125.28%
27,709 $323,000
Q3 2024

Nov 01, 2024

BUY
$19.72 - $27.36 $242,556 - $336,528
12,300 New
12,300 $252,000
Q1 2023

May 03, 2023

BUY
$33.3 - $44.82 $53,779 - $72,384
1,615 Added 22.15%
8,905 $331,000
Q4 2022

Feb 02, 2023

BUY
$33.21 - $62.69 $66,420 - $125,380
2,000 Added 37.81%
7,290 $254,000
Q3 2022

Nov 03, 2022

BUY
$53.92 - $71.7 $67,400 - $89,625
1,250 Added 30.94%
5,290 $292,000
Q2 2022

Jul 28, 2022

BUY
$38.49 - $76.21 $155,499 - $307,888
4,040 New
4,040 $209,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $719M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Privium Fund Management B.V. Portfolio

Follow Privium Fund Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.